Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. (30th August 2013)

• Record Type: Journal Article
• Authors: Danial, C.; Lingala, B.; Balise, R.; Oro, A.E.; Reddy, S.; Colevas, A.; Chang, A.L.S.
• Is Part Of: British journal of dermatology. Volume 169:Number 3(2013:Sep.)
• Page Start: 673
• Page End: 676
• Publication Date: 2013-08-30
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.12333
• Languages: English
• ISSNs: 0007-0963

Abstract

<abstract abstract-type="short" xml:lang="en" id="bjd12333-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>What's already known about this topic?</bold> </p> <p> <list id="bjd12333-list-0001" list-type="bullet"> <list-item> <p>The estimate of overall survival (OS) from date of diagnosis of distant metastatic basal cell carcinoma (BCC) to death is 8–14 months.</p> </list-item> <list-item> <p>This estimate was published in 1984 and needs to be updated.</p> </list-item> </list> </p> <p> <bold>What does this study add?</bold> </p> <p> <list id="bjd12333-list-0002" list-type="bullet"> <list-item> <p>We explored OS in a series of patients from 1997 to 2011 at Stanford Hospital and Clinics.</p> </list-item> <list-item> <p>Our findings suggest that OS in patients with metastatic BCC may be more favourable than previously reported.</p> </list-item> </list> </p> </abstract>